학술논문

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial
Document Type
Article
Source
In The Lancet 2009 373(9671):1253-1263
Subject
Primary Research
Articles
Language
ISSN
0140-6736